These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 7589188)
41. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine. Townsend D; Portoghese PS; Brown DR J Pharmacol Exp Ther; 2004 Jan; 308(1):385-93. PubMed ID: 14569065 [TBL] [Abstract][Full Text] [Related]
42. Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors. Liu JG; Prather PL J Pharmacol Exp Ther; 2002 Sep; 302(3):1070-9. PubMed ID: 12183665 [TBL] [Abstract][Full Text] [Related]
43. X-ray structure of Tyr-D-Tic-Phe-Phe-NH2 (D-TIPP-NH2), a highly potent mu-receptor selective opioid agonist. Comparison with proposed model structures. Flippen-Anderson JL; Deschamps JR; George C; Reddy PA; Lewin AH; Brine GA; Sheldrick G; Nikiforovich G J Pept Res; 1997 May; 49(5):384-93. PubMed ID: 9211219 [TBL] [Abstract][Full Text] [Related]
44. Role of hydrophobic substituents in the interaction of opioid Tyr-Tic dipeptide analogs with dodecylphosphocholine micelles. Molecular partitioning in model membrane systems. Carpenter KA; Wilkes BC; Weltrowska G; Schiller PW Eur J Biochem; 1996 Nov; 241(3):756-64. PubMed ID: 8944763 [TBL] [Abstract][Full Text] [Related]
49. In vitro exposure to peptidic delta opioid receptor antagonists results in limited immunosuppression. House RV; Thomas PT; Bhargava HN Neuropeptides; 1997 Feb; 31(1):89-93. PubMed ID: 9574844 [TBL] [Abstract][Full Text] [Related]
50. Characterization of the bioactive form of linear peptide antagonists at the omega-opioid receptor. Chao TM; Perez JJ; Loew GH Biopolymers; 1996 Jun; 38(6):759-68. PubMed ID: 8652796 [TBL] [Abstract][Full Text] [Related]
51. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor. Amiche M; Sagan S; Mor A; Delfour A; Nicolas P Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911 [TBL] [Abstract][Full Text] [Related]
53. [Role of delta opioid receptors and their ligands in the development of adaptive heart protection against arrhythmogenesis]. Naryzhnaia NV; Krylatov AV; Maslov LN; Lishmanov IuB; Gross GJ; Stephano JB Ross Fiziol Zh Im I M Sechenova; 2001 Dec; 87(12):1617-25. PubMed ID: 11845802 [TBL] [Abstract][Full Text] [Related]
54. Synthesis and pharmacological characterization of a novel, highly potent, peptidomimetic delta-opioid radioantagonist, [3H]Tyr-Tic-(2S,3R)-beta-MePhe-Phe-OH. Birkas E; Kertesz I; Toth G; Bakota L; Gulya K; Szucs M Neuropeptides; 2008 Feb; 42(1):57-67. PubMed ID: 18068762 [TBL] [Abstract][Full Text] [Related]
55. Synaptic actions of neuropeptide FF in the rat parabrachial nucleus: interactions with opioid receptors. Chen X; Zidichouski JA; Harris KH; Jhamandas JH J Neurophysiol; 2000 Aug; 84(2):744-51. PubMed ID: 10938301 [TBL] [Abstract][Full Text] [Related]
56. Extraordinary potency of a novel delta opioid receptor agonist is due in part to increased efficacy. Kramer TH; Bartosz-Bechowski H; Davis P; Hruby VJ; Porreca F Life Sci; 1997; 61(2):129-35. PubMed ID: 9217271 [TBL] [Abstract][Full Text] [Related]
57. Selective delta-opioid receptor antagonist N,N(CH3)2-Dmt-Tic-OH does not reduce ethanol intake in alcohol-preferring AA rats. Ingman K; Salvadori S; Lazarus L; Korpi ER; Honkanen A Addict Biol; 2003 Jun; 8(2):173-9. PubMed ID: 12850776 [TBL] [Abstract][Full Text] [Related]